Phospho-NOS3 (S615) Antibody

Code CSB-PA020135
Size US$100
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
Alternative Names
cNOS antibody; Constitutive NOS antibody; EC NOS antibody; EC-NOS antibody; ecNOS antibody; Endothelial nitric oxidase synthase antibody; Endothelial nitric oxide synthase antibody; Endothelial nitric oxide synthase 3 antibody; Endothelial NOS antibody; eNOS antibody; Nitric oxide synthase 3 (endothelial cell) antibody; Nitric oxide synthase 3 antibody; Nitric oxide synthase 3 endothelial cell antibody; Nitric oxide synthase endothelial antibody; Nitric oxide synthase; endothelial antibody; NOS 3 antibody; NOS III antibody; NOS type III antibody; NOS3 antibody; NOS3_HUMAN antibody; NOSIII antibody
Raised in
Species Reactivity
Synthesized peptide derived from Human NOS3 around the phosphorylation site of S615.
Immunogen Species
Homo sapiens (Human)
Purification Method
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
It differs from different batches. Please contact us to confirm it.
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Tested Applications
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:2000
ELISA 1:40000
Troubleshooting and FAQs
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.; Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1.
Gene References into Functions
  1. NOS3 895(G>T) is significantly associated with recurrence- free survival in patients who received intravesical chemotherapy with pirarubicin after complete transurethral resection. PMID: 30125887
  2. Human gastric cancer tissues with low BUBR1 expression showed no eNOS expression. A decrease in BUBR1 reduced eNOS bioavailability through a pathway other than eNOS phosphorylation. PMID: 30396924
  3. These results suggest that overexpressing or activating eNOS in EOCs increases their survival and enhances their capacity to regulate SMC migration through paracrine effects. PMID: 29343714
  4. This study set out to examine the relationship between renal colic and endothelial nitric oxide synthase gene polymorphisms, but the results show that no relation was found. PMID: 28802544
  5. miR-195 and miR-582 regulated NO release by targeting 3'-UTR of NOS3 post-transcriptionally in endothelial cells PMID: 29948755
  6. binding of IL-5 to IL-5Ralpha receptors enhances angiogenic responses by stimulating the expression of HSP70-1 via the eNOS signaling pathway. PMID: 28317868
  7. that XBP1 splicing can regulate eNOS expression and cellular location, leading to EC migration and therefore contributing to wound healing and angiogenesis PMID: 29352987
  8. Unfavorable genotype of polymorphic variant of candidate gene participating in endothelial dysfunction NOS3 (T786C ) was associated with changes in levels of their active substances in individuals exposed to mercury. PMID: 30351652
  9. 4a/b polymorphism of gene NOS3 in patients with various stages of Pneumoconiosis correlates with early development and unfavorable course of Pneumoconiosis in post-contact period. PMID: 30351692
  10. this study provides that infants with genotype GT eNOS 894G > T have 3.4-fold higher risk of developing of IVH if they are born before 28 + 6 weeks of gestation. PMID: 28211916
  11. Physical interaction between p38 and eNOS was demonstrated by immunoprecipitation, suggesting a novel, NO-independent mechanism for eNOS regulation of TLR4. In correlation, biopsy samples in patients with systemic lupus erythematous showed reduced eNOS expression with associated elevations in TLR4 and p38, suggesting an in vivo link. PMID: 29061842
  12. These results indicated a negative regulatory association between miR24 and NOS3. Downregulation of NOS3 may induce vasospasm following subarachnoid hemorrhage, which may be due to the upregualtion of miR24 in VSMCs. PMID: 29845232
  13. We found a significant relationship between eNOS gene polymorphisms and the congenital heart defects in patients with Down syndrome. Screening for the presence or absence of eNOS polymorphisms may be useful to obtain preliminary data on the risk of congenital heart defects in patients with Down syndrome. PMID: 30204958
  14. Our findings suggest that common genetic polymorphisms in the eNOS gene contribute to risk of erectile dysfunction, presumably by effects on eNOS activity and NO availability. PMID: 29654965
  15. ZYZ-803 stimulated the expression of cystathionine gamma-lyase (CSE) for H2S generation and the activity of endothelial NO synthase (eNOS) for NO production.Blocking CSE and/or eNOS suppressed ZYZ-803-induced H2S and NO production and cardioprotection. PMID: 29288927
  16. Meta-analysis found that eNOS CC genotype was not related to higher susceptibility of migraine compared with TT+ TC genotypes; subgroup analysis showed CC variant increase the risk for migraine compared with TT+ TC genotypes in Caucasian populations, which could not be observed in non-Caucasian populations. There was no significant difference for other genotypes and alleles between migraine patients and healthy controls. PMID: 30200152
  17. This study suggests that T2D patients with different genotypes at CD36, NOS3 and PPARG respond differentially to intervention of omega-3 supplements in blood lipid profiles. PMID: 29703528
  18. Investigated the effect of statins on the expression of sirtuin 1 (SIRT1) and endothelial nitric oxide synthase 3 (eNOS) proteins in young premature myocardial infarction (PMI) patients. Found patients with PMI who were taking statins had a markedly higher level of SIRT1 compared with the controls. The level of eNOS protein was considerably lower in PMI patients compared with the control group. PMID: 29664427
  19. The eNOS-Glu298Asp variant (in mothers and newborns) in association with dyslipidemia (increased cholesterol, LDL and TG levels, and decreased HDL levels) could affect bioavailability of NO and could represent an increased risk for preeclampsia. PMID: 28486825
  20. Increased level of nitric oxide in men with arterial hypeertension did not depend on polymorphic genotypes GG and GT of eNOS gene. PMID: 29658078
  21. The C allele of the eNOS SNP 786 T/C rs2070744 was independently associated with an increased risk for cardiac instability following aneurysmal subarachnoid hemorrhage. PMID: 29079038
  22. A reduction in eNOS and VEGF expression from baseline to the first clinical evaluation may indicate a response to bevacizumab PMID: 28465540
  23. the joint effect of polymorphisms of EDNRB and NOS3 on diabetic retinopathy risk was greater than the individual effect of each polymorphism in the analyzed genetic models PMID: 28817788
  24. polymorphisms in the eNOS "A/A" (homozygous mutant) and ACE "I/D" genotypes might contribute to the increased risk of NSCLC in the South Indian population. PMID: 27328622
  25. The eNOS G894T gene polymorphism was associated with the occurrence and development of coronary heart disease in young people. PMID: 29359785
  26. The frequency of the T allele of eNOS Gene in Type 2 Diabetes was less common than in controls. PMID: 28499789
  27. Our findings suggest that tandem repeat variant within intron 4 of the NOS3 gene is associated with an increased risk of infertility in men diagnosed with idiopathic oligoasthenozoospermia. PMID: 28466478
  28. upregulation of placentaassociated serum exosomal miR155 from patients with preeclampsia may suppress endothelial nitric oxide synthase (eNOS) expression in endothelial cells. PMID: 29328396
  29. eNOS gene SNP rs1808593 genotype may have an important role in predicting the occurrence of pediatric systemic lupus erythematosis and central nervous system complications in pSLE. PMID: 29465350
  30. Findings suggest that NOS3 polymorphisms and physical training are important interacting variables to consider in evaluating redox status, nitric oxide availability and production, and BP control. PMID: 29104725
  31. the eNOS rs1799983 polymorphism and T rs1799983C rs2070744 haplotype might reduce the risk of immunoglobulin A nephropathy in Chinese populations. PMID: 28946141
  32. we reported a novel mechanism for regulation of eNOS uncoupling by low shear stress via autophagy-mediated eNOS phosphorylation, which is implicated in geometrical nature of atherogenesis. PMID: 29466710
  33. NOS3 SNPs are associated with post-exercise hypotension in ethnicity and exercise intensity dependent manner. PMID: 29180482
  34. Acidic pHi reduced NO synthesis and eNOS serine(1177) phosphorylation. Thus, system y(+)L activity is downregulated by an acidic pHi, a phenomenon that may result in reduced NO synthesis in HUVECs. PMID: 29410170
  35. The meta-analysis did not detect any association between eNOS 27VNTR (4b/4a) polymorphism and diabetic microvascular complications susceptibility in Chinese populations. PMID: 29096758
  36. Pitavastatin increases eNOS expression and inhibits of LPS-induced miR-155 expression to prevent HUVEC cell inflammation. PMID: 28664667
  37. 27-bp VNTR polymorphism in intron 4 of eNOS gene polymorphism may be the significant risk factor for systemic lupus erythematosus in south Indian subjects. PMID: 29524578
  38. Our findings provide evidence to support the hypothesis that eNOS -786 T>C polymorphism and the -786C-4a-894G haplotype are associated with the high risk of recurrent pregnancy loss. PMID: 28605668
  39. 6-Gin attenuated the injury of HUVECs induced by HG through the activation of PI3K-AKT-eNOS signal pathway. PMID: 28709132
  40. the two single nucleotide polymorphisms in eNOS gene, G894T and T-786C, are strongly associated with the risk of erectile dysfunction (Meta-Analysis) PMID: 26908069
  41. Extracellular histones disarrange vasoactive mediators release through a COX1-COX2-eNOS interaction in human endothelial cells. PMID: 28244682
  42. rs1799983 NOS3 polymorphism could be associated with hypertension and diastolic blood pressure among Southern Europeans; this association is influenced by dietary fat (saturated fatty acids and monounsaturated fatty acids) and body mass index. PMID: 26994605
  43. The T786C eNOS mutation is common among patients with primary osteonecrosis. PMID: 28877324
  44. Mechanical perturbations sensitize human red blood cell-eNOS to produce nitric oxide. PMID: 27345770
  45. the first work describing the effects of eNOS polymorphisms on different forms of sickle cell disease (SCD), the first enrolling SCD patients of Caucasian origin and the first determining eNOS mRNA levels in peripheral blood from steady-state SCD patients. PMID: 27871907
  46. The development of cholangiocarcinoma (CCA) involves upregulation of eNOS and P-eNOS and their regulators. This may drive angiogenesis and metastasis in CCA. PMID: 27143607
  47. statistically significant correlation didn't exist between serum level of PIN1 and the systolic and diastolic blood pressure, between serum level of eNOS and diastolic blood pressure in the norm tension Alzheimer's disease patients, between serum levels of PIN1, eNOS and systolic blood pressure, and between serum eNOS and systolic and diastolic blood pressure in the patients with hypertension. PMID: 28506742
  48. Study showed the knockdown of VPO1 expression signi fi cantly increased serine1177 phosphorylation of eNOS suggesting that the structural changes and phosphorylation by VPO1 downregulate the expression of eNOS. PMID: 28264790
  49. The -786 T/C polymorphism of NOS3 gene is a susceptibility marker of COPD among Tunisians that correlates with nitric oxide levels and airflow obstruction. PMID: 28526204
  50. Results showed that eNOS and XRCC4 VNTR variants might play a potential role in schizophrenia + nicotine dependence and/or nicotine dependence pathophysiology. PMID: 29050484

Show More

Hide All

Involvement in disease
Variation Asp-298 in NOS3 may be associated with susceptibility to coronary spasm.
Subcellular Location
Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Note=Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity.
Protein Families
NOS family
Tissue Specificity
Platelets, placenta, liver and kidney.
Database Links

HGNC: 7876

OMIM: 163729

KEGG: hsa:4846

STRING: 9606.ENSP00000297494

UniGene: Hs.647092

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details


II. Contact details


III. Ship To


IV. Bill To